Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07194447Completed
Randomised, double-blind trial of simvastatin gel (Ain Shams University) in Alveolar bone loss (2 arms). Primary endpoint: Implant Stability Quotient at 16 weeks. Started Oct 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07194447.